CB-10-YX20_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, 2-(2-Phenylethenyl)-4-(pyridin-3-ylmethylidene)-4,5-dihydro-1,3-oxazol-5-one, DAPK1/3 inhibitor targeting DAPK1 (Novartis, 2360773)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/2360773
Similar Terms
Downloads & Tools

Genes

8 genes differentially expressed following the CB-10-YX20_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
OAZ1 ornithine decarboxylase antizyme 1 0.670047
RERGL RERG/RAS-like 0.483947
THOC6 THO complex 6 0.386575
MT1E metallothionein 1E 0.250631
NDUFS7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) 0.250631
VCX variable charge, X-linked 0.244192
RPL18A ribosomal protein L18a 0.225931

decreased expression

Symbol Name Standardized Value
RPL11 ribosomal protein L11 -0.248034